ANSES's French Agency for Veterinary Medicinal Products inaugurates its new building
The French Agency for Veterinary Medicinal Products (ANMV) inaugurated its new building today, in the presence of Roger Genet, Director General of ANSES, Loïg Chesnais-Girard, President of the Brittany Regional Council, Jean-Luc Chenut, President of the Ille-et-Vilaine Departmental Council and Jean-Pierre Orand, Director of the ANMV.
Exposure to crystalline silica poses high risks for worker health
ANSES is today publishing the results of its expert appraisal on health risks for workers in France exposed to crystalline silica, a mineral used or present in many different industries. In France, nearly 365,000 workers could potentially be exposed to respirable crystalline silica, mainly from quartz. ANSES estimates that between 23,000 and 30,000 workers could be exposed to levels exceeding the occupational exposure limit (OEL) of 0.1 mg.m‑3 currently in force. In light of the evidence on the health effects associated with crystalline silica and estimated exposure levels, the Agency has concluded that there is a particularly high health risk for workers exposed to levels that are equal to or above the current OEL. ANSES is therefore issuing a series of recommendations to emphasise prevention of exposure, revise the OEL, enhance medical surveillance and begin revising existing occupational disease tables.
LEDs: ANSES’s recommendations for limiting exposure to blue light
Now that the use of LEDs for lighting has become widespread and the number of LED objects has proliferated, ANSES is publishing an update of its 2010 expert appraisal on the health effects of LEDs in light of new scientific knowledge. The Agency confirms the toxicity of blue light on the retina and highlights the biological rhythm and sleep disruption associated with exposure to blue light in the evening or at night, particularly via screens and especially for children. The Agency therefore recommends limiting the use of LED devices with the highest blue-light content, especially for children, and reducing light pollution as much as possible to preserve the environment.
Caroline Semaille appointed Managing Director General of the Regulated Products Division
Caroline Semaille was appointed Managing Director General of the ANSES Regulated Products Division on 29 April 2019. She succeeds Françoise Weber, who decided to retire. Ms Semaille, a Public Health Hospital Practitioner, will now coordinate the Agency’s various departments responsible for the assessment and marketing authorisations of plant protection products, fertilisers, growing media, adjuvants, active substances, biocidal products and veterinary medicinal products.
Skin allergies: restrict chemicals in textiles, leather, fur and hides
In order to protect consumers more effectively from the risks of skin allergies, ANSES and the Swedish Chemicals Agency (KEMI) have jointly submitted a restriction proposal for sensitising substances under the European chemicals regulation (REACh). This proposal aims to ban or limit more than a thousand skin allergens in articles made from textiles, leather, fur and hides.
On 8 July 2019, ANSES and the ANR will once again join together to host a one-day event to present the results of research projects funded by the two institutions. This second event in the series will focus on endocrine disruptors, and more specifically on the scientific developments concerning exposure to these substances, their effects on human health and their mechanisms of action. Registration is closed. This event will be held in French only. Contact
Food additive E171: ANSES reiterates its recommendations for consumer safety
The food additive E171, which consists of titanium dioxide (TiO2) particles, mainly in nanoparticle form, is used in many different food products. Following the expert appraisal work it conducted in 2017, ANSES was asked in February 2019 to review the most recent studies on the oral toxicology of E171 and to update its recommendations. On completion of this expert appraisal, the Agency concluded that it had not obtained any new information to resolve the uncertainties regarding the safety of the additive E171. Pending a better characterisation of the hazards and risks posed by E171, it reiterates its general recommendations on nanomaterials, aimed mainly at limiting the exposure of workers, consumers and the environment, by promoting safe alternatives with equivalent effectiveness.
Monitoring drinking water quality and protecting human health: ANSES proposes a method for identifying relevant pesticide metabolites
Pesticides disperse into the natural environment where they can transform into one or more other compounds called "metabolites". These chemical metabolites can potentially contaminate water resources and even water supplied to consumers. Water quality controls are increasingly detecting situations where regulatory quality limits are exceeded, meaning that management measures are needed before distribution. In order to address these challenges, the Directorate General for Health asked ANSES to define a methodology for identifying the relevant metabolites regulated by the European Drinking Water Directive. ANSES therefore presented the management authorities with a method for identifying which pesticide metabolites warrant priority attention with regard to the health issues associated with drinking water consumption.
Titanium dioxide in nanoparticle form: ANSES defines a toxicity reference value (TRV) for chronic inhalation exposure
Titanium dioxide in nanoparticle form (TiO 2 -NP) is used in many industrial and commercial applications. ANSES was asked to define a toxicity reference value (TRV) for this substance as part of its national mission to develop health reference values. Following an in-depth analysis of all the available toxicity data, the Agency is recommending a chronic TRV by inhalation for the P25 form of TiO 2 -NP of 0.12 µg/m -3 . This reference value will be used when conducting health risk assessments as part of the management of industrial facilities and sites in France. It is also the first TRV developed for a nanomaterial in France.